{
    "paper_id": "PMC7166509",
    "metadata": {
        "title": "Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia",
        "authors": [
            {
                "first": "Ning",
                "middle": [],
                "last": "Tang",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Dengju",
                "middle": [],
                "last": "Li",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Xiong",
                "middle": [],
                "last": "Wang",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Ziyong",
                "middle": [],
                "last": "Sun",
                "suffix": "",
                "email": "499388475@qq.com",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Since December 2019, novel coronavirus pneumonia (NCP) cases have emerged in Wuhan, China, and the 2019 novel coronavirus (2019\u2010nCoV) was confirmed as the cause of the NCP.\n1\n The number of infected patients in China has increased rapidly and exceeded 60 000 in mid\u2010February 2020. In previous reports,\n2\n, \n3\n, \n4\n the clinical characteristics of NCP patients have been investigated, the reported mortalities were 4.3%, 11.0%, and 14.6%, respectively; organ dysfunction and coagulopathy were associated with high mortality. However, the complete coagulation parameters of NCP cases were not fully reported, which may have prognostic values and be important therapeutic targets. In this study, the coagulation parameters of consecutive NCP cases in our hospital were shown and the differences between survivors and non\u2010survivors were investigated.",
            "cite_spans": [],
            "section": "INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "Consecutive patients with confirmed NCP admitted to Tongji Hospital of Huazhong University of Science and Technology in Wuhan from January 1 to February 3, 2020, were enrolled. This study was approved by the Ethics Committee of Tongji Hospital (Wuhan, China). The diagnosis of NCP was according to World Health Organization interim guidance\n5\n and confirmed by RNA detection of the 2019\u2010nCoV in the clinical laboratory of Tongji Hospital. The clinical outcomes were monitored up to February 13, 2020.",
            "cite_spans": [],
            "section": "METHODS",
            "ref_spans": []
        },
        {
            "text": "The samples for coagulation tests were collected on admission and during the hospital stay: prothrombin time (PT), activated partial thromboplastin time (APTT), antithrombin activity (AT), fibrinogen, fibrin degradation product (FDP), and D\u2010dimer were detected using a STA\u2010R MAX coagulation analyzer and original reagents (Diagnostica Stago, Saint\u2010Denis, France).",
            "cite_spans": [],
            "section": "METHODS",
            "ref_spans": []
        },
        {
            "text": "Between survivors and non\u2010survivors, normally and abnormally distributed quantitative variables were compared using the Student's t test and the Mann\u2010Whitney U test, respectively. Categorical variables were compared using the chi\u2010squared test. The results were given as the mean \u00b1 standard deviation, median (interquartile range), or number (percentage), wherever appropriate. A P\u2010value of < .05 was considered statistically significant. Data were analyzed using SPSS 21.0 for Windows (SPSS Inc.).",
            "cite_spans": [],
            "section": "METHODS",
            "ref_spans": []
        },
        {
            "text": "There were 183 patients (85 females and 98 males) with NCP enrolled into the study, and these patients had complete clinical information and the laboratory data required for this study. The mean age at disease onset was 54.1 years (range, 14\u201094 years). Seventy\u2010five (41.0%) patients had chronic diseases, including cardiovascular and cerebrovascular diseases, respiratory system disease, malignant tumor, chronic liver and kidney disease, and others. All patients received antiviral and supportive therapies after diagnosis. By the end of February 13, 78 (42.6%) patients had been discharged and 21 (11.5%) patients had died, the rest 84 (45.9%) of the patients remain hospitalized in stable condition.",
            "cite_spans": [],
            "section": "RESULTS AND DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "The coagulation parameters on admission between survivors and non\u2010survivors were compared (Table 1). Based on our detection system, the reportable range of D\u2010dimer and FDP were 0.22\u201021.00 \u00b5g/mL and 4.0\u2010150.0 \u00b5g/mL, respectively. The dynamic changes in coagulation parameters were tracked from day 1 to day 14 after admission at three\u2010day intervals (Figure 1).",
            "cite_spans": [],
            "section": "RESULTS AND DISCUSSION",
            "ref_spans": [
                {
                    "start": 356,
                    "end": 357,
                    "mention": "1",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 97,
                    "end": 98,
                    "mention": "1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "According to the International Society on Thrombosis and Haemostasis (ISTH) diagnostic criteria for disseminated intravascular coagulation (DIC),\n6\n 15 (71.4%) of the non\u2010survivors matched the grade of overt\u2010DIC (\u22655 points) in later stages of NCP (Table 2), the median time from admission to DIC was 4 days (range, 1\u201012 days). On the contrary, only one (0.6%) survivor matched the DIC criteria during hospital stay.",
            "cite_spans": [],
            "section": "RESULTS AND DISCUSSION",
            "ref_spans": [
                {
                    "start": 254,
                    "end": 255,
                    "mention": "2",
                    "ref_id": "TABREF1"
                }
            ]
        },
        {
            "text": "In our enrolled patients with NCP, the non\u2010survivors revealed significantly higher D\u2010dimer and FDP levels, and longer PT compared to survivors on admission. By the late hospitalization, the fibrinogen and AT levels were also significantly lower in non\u2010survivors; this suggested that conventional coagulation parameters during the course of NCP were significantly associated with prognosis.",
            "cite_spans": [],
            "section": "RESULTS AND DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "DIC appeared in most of the deaths. Patients presenting with a virus infection may develop into sepsis associated with organ dysfunction. Sepsis is well established as one of the most common causes of DIC; development of DIC results when monocytes and endothelial cells are activated to the point of cytokine release following injury, with expression of tissue factor and secretion of von Willebrand factor. Circulation of free thrombin, uncontrolled by natural anticoagulants, can activate platelets and stimulate fibrinolysis.\n8\n At the late stages of NCP, levels of fibrin\u2010related markers (D\u2010dimer and FDP) moderately or markedly elevated in all deaths, which suggested a common coagulation activation and secondary hyperfibrinolysis condition in these patients.",
            "cite_spans": [],
            "section": "RESULTS AND DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "In a previous study,\n9\n Gralinski et al investigated viral pathogenesis and identified a novel host pathway involved in severe acute respiratory syndrome (SARS)\u2010coronavirus disease progression. Their data suggest that dysregulation of the urokinase pathway during SARS\u2010coronavirus infection contributes to more severe lung pathology and that plasminogen activator inhibitor\u20101 plays a protective role following infection. In addition, Fatma Berri et al\n10\n reported that plasminogen contributes to inflammation caused by influenza through fibrinolysis, and 6\u2010aminocaproic acid can protect against influenza. Presumably, fibrinolysis may also be induced following severe 2019\u2010nCoV infection.",
            "cite_spans": [],
            "section": "RESULTS AND DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "The limitations of this report included that, as a relatively small, single\u2010center study, the mortality and characteristics of enrolled patients may not be representative; our findings should be confirmed in an adequately powered clinical study. In addition, some patients are still hospitalized at the time of manuscript submission. Nonetheless, the present study has shown that existence of DIC is common in deaths with NCP; abnormal coagulation results, especially markedly elevated D\u2010dimer and FDP, may have the potential to guide therapy and evaluate prognosis.",
            "cite_spans": [],
            "section": "RESULTS AND DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "N. Tang and X. Wang collected the clinical data and processed statistical data. N. Tang and D. Li drafted and revised the manuscript. Z. Sun designed and guided the study.",
            "cite_spans": [],
            "section": "AUTHOR CONTRIBUTIONS",
            "ref_spans": []
        },
        {
            "text": "The authors declare that they have no conflicts of interest.",
            "cite_spans": [],
            "section": "CONFLICTS OF INTEREST",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 1: Coagulation parameters of NCP patients on admission\n",
            "type": "table"
        },
        "TABREF1": {
            "text": "Table 2: The grade of DIC in non\u2010survivors with NCP (n = 21)\n",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Figure 1: Dynamic profile of coagulation parameters in patients with novel coronavirus pneumonia (NCP). Timeline charts illustrate the changes of coagulation parameters in 183 patients with NCP (21 non\u2010survivors and 162 survivors) after admission. The error bars show medians and 25% and 75% percentiles. The horizontal lines show the upper normal limits of prothrombin time, activated partial thromboplastin time, D\u2010dimer and fibrin degradation product, and the lower normal limits of fibrinogen and antithrombin activity, respectively. a\nP < 0.05 for survivors versus non\u2010survivors",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China, 2019",
            "authors": [],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "382",
            "issn": "8",
            "pages": "727-733",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study",
            "authors": [],
            "year": 2020,
            "venue": "Lancet.",
            "volume": "395",
            "issn": "10223",
            "pages": "507-513",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",
            "authors": [],
            "year": 2020,
            "venue": "Lancet.",
            "volume": "395",
            "issn": "10223",
            "pages": "497-506",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2010infected pneumonia in Wuhan, China",
            "authors": [],
            "year": 2020,
            "venue": "JAMA",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1001/jama.2020.1585"
                ]
            }
        },
        "BIBREF4": {
            "title": "Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation",
            "authors": [],
            "year": 2001,
            "venue": "Thromb Haemost.",
            "volume": "86",
            "issn": "5",
            "pages": "1327-1330",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Use of soluble fibrin antigen instead of D\u2010dimer as fibrin\u2010related marker may enhance the prognostic power of the ISTH overt DIC score",
            "authors": [],
            "year": 2004,
            "venue": "Thromb Haemost.",
            "volume": "91",
            "issn": "4",
            "pages": "812-818",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC)",
            "authors": [],
            "year": 2009,
            "venue": "Educ Program Am Soc Hematol",
            "volume": "2009",
            "issn": "1",
            "pages": "240-246",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Mechanisms of severe acute respiratory syndrome coronavirus\u2010induced acute lung injury",
            "authors": [],
            "year": 2013,
            "venue": "mBio.",
            "volume": "4",
            "issn": "4",
            "pages": "e00271-e313",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis",
            "authors": [],
            "year": 2013,
            "venue": "PLoS Pathog.",
            "volume": "9",
            "issn": "3",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        }
    }
}